Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 10.28B 2.74B 2.39B 2.21B 2.04B 3.84B 264B 3.92B 26.39B 10.38B 129B 10.06B 445B P/E 2026 *
19.7x
P/E 2027 * -
Enterprise Value 9.97B 2.65B 2.32B 2.14B 1.97B 3.72B 256B 3.8B 25.58B 10.06B 125B 9.75B 431B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 5.28x
Free-Float
38.61%
Yield 2026 *
3.05%
Yield 2027 * 3.39%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-1.34%
1 week-0.27%
Current month-5.23%
1 month-8.42%
3 months-5.65%
6 months+4.78%
Current year+3.23%
1 week 144.8
Extreme 144.8
148.9
1 month 144.8
Extreme 144.8
163.7
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
180.1
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-0.27%-15.72%+19.24% 2.74B
-0.90%-0.31%+13.62%+80.12% 48.56B
-0.23%-0.63%+67.00%+115.81% 35.65B
-0.76%-1.57%-3.87%+37.62% 11.98B
-0.88%-1.32%+18.04%+92.11% 11.95B
+1.31%+1.90%+34.67%+129.06% 9.29B
-0.75%-0.17%+18.85%+36.91% 6.95B
+3.37%-0.96%+46.11%-4.38% 6.79B
-2.25%-1.40%+1.39%+218.40% 6.7B
-9.93%+5.82%-22.89%+16.29% 6.81B
Average -1.24%+0.48%+15.72%+74.12% 14.74B
Weighted average by Cap. -0.87%+0.32%+25.75%+85.63%

Financials

2026 *2027 *
Net sales 1.62B 431M 376M 347M 320M 603M 41.46B 617M 4.15B 1.63B 20.31B 1.58B 69.91B 1.87B 498M 435M 402M 370M 698M 47.98B 713M 4.8B 1.89B 23.5B 1.83B 80.89B
Net income 521M 139M 121M 112M 103M 194M 13.36B 199M 1.34B 526M 6.54B 510M 22.52B -
Net Debt -317M -84.41M -73.77M -68.07M -62.74M -118M -8.13B -121M -814M -320M -3.98B -310M -13.7B -404M -108M -94.01M -86.75M -79.96M -151M -10.36B -154M -1.04B -408M -5.07B -395M -17.47B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-16 SAR 146.90 -1.34% 18,428
26-07-15 SAR 148.90 +2.69% 46,390
26-07-14 SAR 145.00 -1.09% 13,093
26-07-13 SAR 146.60 -0.81% 92,857
26-07-12 SAR 147.80 +0.34% 21,228
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
146.90SAR
Average target price
164.24SAR
Spread / Average Target
+11.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock